Apply safety and efficacy data from clinical trials and real-world studies of new and emerging agents to achieve an individualized, patient-centered approach to UC management
|
|
|
|
|
|
Interpret the updated UC guidelines to improve treatment decision making and care of patients
|
|
|
|
|
|
Evaluate potential approaches for positioning new and emerging therapies for UC
|
|
|
|
|
|
Describe clinical situations in which novel therapies may be advantageous for patients with complex IBD
|
|
|
|
|
|